PUBLICATIONS

  • ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells

    July 2024

  • Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys

    May 2024

  • Plate reader spectroscopy as an alternative to atomic absorption spectroscopy for the assessment of nanoparticle cellular uptake

    November 2022

  • Effective reduction of SARS-CoV-2 RNA levels using a tailor-made oligonucleotide-based RNA inhibitor

    April 2022

  • Differences in surface chemistry of iron oxide nanoparticles result in different routes of internalization

    April 2021

  • Surface coating determines the inflammatory potential of magnetite nanoparticles in murine renal podocytes and mesangial cells

    July 2020

  • Chronic myelogenous leukemia on target

    June 2018

  • Selective therapeutic intervention: A challenge against off-target effects

    July 2017

  • Gene expression patterns as predictive biomarkers in hematology-oncology: Principal hurdles on the road to the clinic

    January 2017

  • Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?

    October 2016

  • Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia

    April 2016

error: Content is protected !!